➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Mallinckrodt
McKesson
Dow
Boehringer Ingelheim

Last Updated: June 1, 2020

DrugPatentWatch Database Preview

Drug Sales Trends for VESTURA


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for VESTURA (2017)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $3,017,581
INSIDE ANOTHER STORE $372,207
[disabled in preview] $86,311,703
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 28,948
INSIDE ANOTHER STORE 8,262
[disabled in preview] 1,726,655
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $740,150
PRIVATE INSURANCE $86,091,568
[disabled in preview] $2,869,774
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for VESTURA
Drug Units Sold Trends for VESTURA

Annual Sales Revenues and Units Sold for VESTURA

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
VESTURA   Start Trial   Start Trial 2017
VESTURA   Start Trial   Start Trial 2016
VESTURA   Start Trial   Start Trial 2015
VESTURA   Start Trial   Start Trial 2014
VESTURA   Start Trial   Start Trial 2013
VESTURA   Start Trial   Start Trial 2012
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Harvard Business School
Johnson and Johnson
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.